医学
癌症
肾脏疾病
重症监护医学
肾毒性
多学科方法
内科学
肾癌
肾
疾病
社会科学
社会学
作者
Jolanta Małyszko,Petra Tesařová,Giovambattista Capasso,Anna Capasso
出处
期刊:The Lancet
[Elsevier]
日期:2020-07-01
卷期号:396 (10246): 277-287
被引量:87
标识
DOI:10.1016/s0140-6736(20)30540-7
摘要
Acute and chronic kidney disease encompasses a complex set of diseases that can both lead to, and result from, cancer. In particular, kidney disease can arise from the use of chemotherapeutic agents. Many of the current and newly developed cancer chemotherapeutic agents are nephrotoxic and can promote kidney dysfunction, which frequently manifests during the terminal stages of cancer. Given the link between kidney disease and cancer development and treatment, the aim of this Review is to highlight the importance of multidisciplinary collaboration between oncologists and nephrologists to predict and prevent chemotherapeutic-induced nephrotoxicity. As new therapies are introduced to treat cancer, new renal toxicities require proper diagnosis and management. We anticipate that multidisciplinary collaborations will lead to the development and implementation of guidelines for clinicians to improve the therapeutic management of patients with both cancer and renal impairment.
科研通智能强力驱动
Strongly Powered by AbleSci AI